CPT-CEF treatment at increasing concentration showed an increasing trend in the number of HT29 cells at G1 phase and a decreasing trend in those at S phase and G2/M phase (Fig. 12 ).
← all excerpts
Efficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe<sub>3</sub>O<sub>4</sub> nanoparticle-conjugated nanocarriers as an anti-colon cancer (HT29) drug.
2
—
—
The sentences
The data clearly show an increasing trend in early stage apoptosis with increasing concentration of CPT-CEF.